Kaoru Hamada
About
In The Last Decade
Kaoru Hamada
51 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 1.3k
- Immunology 924
- Pulmonary and Respiratory Medicine 516
- Molecular Biology 316
- Surgery 311
Countries citing papers authored by Kaoru Hamada
This map shows the geographic impact of Kaoru Hamada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Hamada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Hamada more than expected).
Fields of papers citing papers by Kaoru Hamada
This network shows the impact of papers produced by Kaoru Hamada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Hamada. The network helps show where Kaoru Hamada may publish in the future.
Co-authorship network of co-authors of Kaoru Hamada
This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Hamada. A scholar is included among the top collaborators of Kaoru Hamada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Hamada. Kaoru Hamada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | Clinical Significance and Therapeutic Potential of the Programmed Death-1 Ligand/Programmed Death-1 Pathway in Human Pancreatic Cancer breakdown → | 729 |
| 5 | 5 | |
| 6 | 68 | |
| 7 | 60 | |
| 8 | 40 | |
| 9 | 5 | |
| 10 | 25 | |
| 11 | 0 | |
| 12 | 42 | |
| 13 | Expression of IL-12 mRNA in peripheral blood mononuclear cells from inoperable non-small cell lung cancer patients treated with clarithromycin. | 3 |
| 14 | 1 | |
| 15 | [Expression of activation antigen, CD69, on human local eosinophils]. | 1 |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 7 | |
| 19 | 0 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.